Skip to main content
. 2022 Jul 16;14(7):e26909. doi: 10.7759/cureus.26909

Table 4. Univariate analysis of variables associated with mortality in COVID-19 patients.

*p<0.05 was considered significant.

AST: aspartate transaminase; ALT: alanine transaminase; APTT: activated partial thromboplastin time; CRP: C-reactive protein; PT: prothrombin time; WBC: white blood cell

Variables Odds ratio p-value 95% confidence interval  
Age        
<40 1      
>40 6.38 0.000 4.818-8.466  
Sex        
Male 1      
Female 0.50 0.000 0.401-0.612  
Laboratory investigations        
Hemoglobin        
11-14 1      
<11 0.94 0.961 0.807-1.226  
>11 0.80 0.132 0.607-1.067  
WBC (×103/uL)        
5-11 1      
<5 0.71 0.080 0.495-1.040  
>11 3.90 0.000 3.206-4.760  
Lymphocyte        
20%-40% 1      
<20% 11.17 0.000 11.101-21.469  
>40% 0.55 0.180 0.233-1.310  
Neutrophil        
40%-60% 1      
<40% 3.39 0.006 1.424-8.091  
>60% 19.84 0.000 11.803-33.367  
N/L ratio        
<3.5 1      
>3.5 1.31 0.720 0.297-5.791  
Platelet (×103/uL)        
150-450 1      
<150 1.48 0.000 1.237-1.771  
>450 1.18 0.546 0.685-2.044  
AST        
<50 1      
>50 5.10 0.000 4.185-6.223  
ALT        
<50  1      
>50 2.25 0.000 1.829-2.769  
APTT        
<33 1      
>33 3.71 0.000 2.800-4.923  
Creatinine        
<1.3  1      
>1.3 3.07 0.000 2.562-3.697  
CRP        
<24 1      
>24 8.311 0.000 3.838-17.994  
Ferritin        
<500 1      
500-1,000 11.40 0.000 6.659-19.537  
>1,000 14.88 0.000 9.583-23.118  
Comorbidities        
Hypertension 2.85 0.000 2.394-3.413  
Chronic cardiac diseases 3.09 0.000 2.357-4.066  
Diabetes 3.05 0.000 2.554-3.651  
Chronic lung disease 3.00 0.000 1.796-5.009  
Chronic kidney disease 4.54 0.000 3.423-6.034  
Liver diseases 4.31 0.000 2.409-7.741  
Chronic neurological disorder 2.70 0.001 1.478-4.941  
Obesity 4.91 0.002 1.810-13.338  
Thyroid disorder 0.88 0.540 0.587-1.321  
Cancer 1.44 0.224 0.798-2.610